-
Scientific breakthroughs, AI, advanced therapeutics, and medical devices are radically altering the way healthcare is discovered, developed, and delivered across the globe.
Pressure to accelerate clinical pipelines, reduce manufacturing costs, secure supply chains, and demonstrate clinical value continue to intensify.
Meanwhile, demographic drivers - an ageing population, a rise in chronic complex illnesses, and a growing demand for personalised, preventative medicine - demand continuous innovation and fresh insight from the laboratory to the bedside.
While established pharmaceutical and healthcare providers continue to play a major role in securing the health of the nation, life sciences pioneers, biotech start-ups, and medical device innovators are disrupting traditional models of reactive medicine with targeted therapies and diagnostics.
Whether you are a life sciences start-up, an established medical technology SME seeking to scale and export, an investor financing the next breakthrough, or an NHS trust adopting advanced therapeutics, Bevan Brittan’s Life Sciences Team can advise you and help you to thrive.
Because we operate in your world, we know what it takes for you to thrive in it
Our Life Sciences legal and regulatory team are experts in supporting clients through the complex lifecycles of biotechnology, pharmaceuticals, and medical devices. We understand the necessity of working across cross-functional partnerships, academic research institutions, and strict regulatory frameworks.
We provide a comprehensive, integrated Life Sciences advice service, drawing upon specialised expertise across the firm’s Corporate, Commercial, Intellectual Property, Technology, Regulatory and Dispute teams.
Whether your priority is rapid commercialisation, securing early-stage funding, or navigating rigorous market access and compliance pathways, our lawyers have the agility to look at problems from different perspectives. We offer expert commercial, legal, and regulatory support to help your scientific ventures succeed.
-
The Christie NHS Foundation Trust: Advised on the multi-million-pound redevelopment of a Manchester cancer research centre in collaboration with the University of Manchester and Cancer Research UK Limited.
Academic Health Science Network (AHSN): Structured and negotiated equity investments into three biotech/medical science companies
NHS England & NHS Digital: Advising on data sharing, remote consultation, AI, medical device regulation and digital health technology.
We advise fertility clinics on a broad range of regulatory, governance and operational issues, alongside acting in complex fertility-related disputes and group claims. Our team has specialist expertise in the Human Fertilisation and Embryology Act (HFEA) and a strong understanding of the legal and commercial challenges facing the fertility sector.
Advised a fertility provider in relation to a group action arising from fertility treatment claims, coordinating litigation strategy, regulatory issues, and reputational risk management to achieve a pragmatic resolution.
Legal Insights
